| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |